Ventral anterior foregut endoderm cells as progenitors for airway epithelial cell replacement in primary ciliary dyskinesia

No abstract is available for this paper.

• Publication year

  2026

• Venue

  bioRxiv

• Publication date

  2026-02-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.64898/2026.02.05.701025
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary ciliary dyskinesia

  2025cited by this paper
• Unlocking the Future: Pluripotent Stem Cell-Based Lung Repair

  2024cited by this paper
• Airway hillocks are injury-resistant reservoirs of unique plastic stem cells

  2024cited by this paper
• Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications

  2024cited by this paper
• Recent advances in lung organoid development and applications in disease modeling

  2023cited by this paper
• The challenge of diagnosing primary ciliary dyskinesia: a commentary on various causative genes and their pathogenic variants

  2023cited by this paper
• Perspectives for Primary Ciliary Dyskinesia

  2022cited by this paper
• Towards an artificial human lung: modelling organ-like complexity to aid mechanistic understanding

  2022cited by this paper
• CRISPR/Cas9-mediated gene knockout and interallelic gene conversion in human induced pluripotent stem cells using non-integrative bacteriophage-chimeric retrovirus-like particles

  2022cited by this paper
• A human fetal lung cell atlas uncovers proximal-distal gradients of differentiation and key regulators of epithelial fates

  2022cited by this paper
• Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies

  2021cited by this paper
• Current and Future Treatments in Primary Ciliary Dyskinesia

  2021cited by this paper
• Application of iPSC to Modelling of Respiratory Diseases

  2021cited by this paper
• Differentiation of human induced pluripotent stem cells into functional airway epithelium

  2020cited by this paper
• Understanding primary ciliary dyskinesia and other ciliopathies.

  2020cited by this paper
• Generation of the induced pluripotent stem cell line UHOMi002-A from peripheral blood mononuclear cells of a healthy male donor.

  2020cited by this paper
• Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges.

  2020cited by this paper
• Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis

  2019cited by this paper
• Induced Pluripotent Stem Cells for Primary Ciliary Dyskinesia Modeling and Personalized Medicine

  2018cited by this paper
• Advances in the Genetics of Primary Ciliary Dyskinesia: Clinical Implications

  2018cited by this paper
• Prospective isolation of NKX2-1–expressing human lung progenitors derived from pluripotent stem cells

  2017cited by this paper
• Transplantation of Airway Epithelial Stem/Progenitor Cells: A Future for Cell‐Based Therapy

  2017cited by this paper
• Efficient Derivation of Functional Human Airway Epithelium from Pluripotent Stem Cells via Temporal Regulation of Wnt Signaling.

  2017cited by this paper
• Dual SMAD Signaling Inhibition Enables Long-Term Expansion of Diverse Epithelial Basal Cells.

  2016cited by this paper
• Gene editing of DNAH11 restores normal cilia motility in primary ciliary dyskinesia

  2016cited by this paper
• Restoring ciliary function to differentiated Primary Ciliary Dyskinesia cells with a lentiviral vector

  2014cited by this paper
• p63+Krt5+ distal airway stem cells are essential for lung regeneration

  2014cited by this paper
• MCIDAS mutations result in a mucociliary clearance disorder with reduced generation of multiple motile cilia

  2014cited by this paper
• Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells.

  2012cited by this paper
• Basal cells as stem cells of the mouse trachea and human airway epithelium

  2009cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Current status of gene therapy for inherited lung diseases.

  2003cited by this paper
• Final Report on the Safety Assessment of EDTA, Calcium Disodium EDTA, Diammonium EDTA, Dipotassium EDTA, Disodium EDTA, TEA-EDTA, Tetrasodium EDTA, Tripotassium EDTA, Trisodium EDTA, HEDTA, and Trisodium HEDTA

  2002cited by this paper
• Increasing epithelial junction permeability enhances gene transfer to airway epithelia In vivo.

  2000cited by this paper

• No citing papers are available for this paper.